-

Continuum Clinical Names Paul Ivsin as Vice President of Data & Analytics

NORTHBROOK, Ill.--(BUSINESS WIRE)--Continuum Clinical, a global clinical trial enrollment company, is proud to announce Paul Ivsin as the new vice president of data and analytics. Ivsin joins Continuum with more than 20 years’ experience in the patient recruitment industry. Most recently, he was the managing director of patient recruitment for Seeker Health, where he led all clinical trial and patient engagement strategy.

In this newly-created role at Continuum, Ivsin will be responsible for enhancing analysis and utilization of the data amassed by the company’s best-in-class ContinuVue® reporting platform. Further, Ivsin will support the expansion of the platform’s infrastructure and capability. Continuum aims to expand its focus on data-driven recruitment strategies that will impact all aspects of a sponsor’s program.

“I’m excited to join Continuum and help unlock ContinuVue’s enormous potential for generating insights,” said Ivsin, “I look forward to deepening the data-driven culture at Continuum and strengthening the influence of data throughout the organization. We want to create an organization where every employee—not just analysts or specialists—feels empowered to understand and use data to make effective decisions.”

Continuum has long utilized ContinuVue® to power its business and projects with rapid data analysis and identification of key trends which are used to generate program insights and forecasts that directly impact sponsors’ ability to meet or exceed clinical trial enrollment milestones. The company’s sponsors continue to face immense pressure to achieve clinical milestones faster and with greater accuracy. The easily-configurable structure of ContinuVue® enables sponsors to aggregate multiple sources of enrollment and vendor data to create a single source of truth for enrollment.

“We’re thrilled to have a thought leader like Paul join our diverse team of thinkers,” said Neil Weisman, president of Continuum Clinical. “Paul will help provide our sponsors with even more value and insight, bringing greater meaning to our mission of Going Beyond Delivering More.”

About Continuum Clinical

Continuum Clinical is a global clinical trial enrollment company, providing fact-based patient recruitment solutions that deliver results. With over twenty-five years of experience, Continuum Clinical provides sponsors and CROs with patient recruitment and retention planning, study and site support, patient recruitment campaigns, patient advocacy and diversity & inclusion services, retention solutions, and reporting and analytics. We specialize in identifying and solving challenges that can impact successful clinical trial enrollment, from protocol development through study completion. Headquartered in the US, Continuum Clinical has more than 140 employees in the US and Europe and an expanded network of resources worldwide.

Contacts

Courtney Cymerman
ccymerman@continuumclinical.com
Corporate Brand & Content Specialist
847-418-8040

Continuum Clinical


Release Summary
Continuum Clinical, a global clinical trial enrollment company, is proud to announce Paul Ivsin as the new vice president of data and analytics.
Release Versions

Contacts

Courtney Cymerman
ccymerman@continuumclinical.com
Corporate Brand & Content Specialist
847-418-8040

More News From Continuum Clinical

Survey Shows 68% of Americans Now More Interested in Clinical Trial Participation as COVID-19 News Continues to Boost Awareness of Medical Research

NORTHBROOK, Ill.--(BUSINESS WIRE)--Survey shows 68% of Americans now more interested in clinical trial participation as COVID-19 news continues to boost awareness of medical research....

Survey Shows One Third of Clinical Trial Study Sites Fear Total Closure; 77% Indicate at Least Some Ongoing Research Trials Have Been Impacted Due to COVID-19

NORTHBROOK, Ill.--(BUSINESS WIRE)--Continuum Clinical and the Association of Clinical Research Professionals (ACRP) conduct survey on the impact of COVID-19 on clinical trial sites....

US clinical trial site concerns over COVID-19 impact on enrollment jumps by 124% over past week

NORTHBROOK, Ill.--(BUSINESS WIRE)--In one week, US clinical research study sites’ concern about COVID-19-related interruptions to recruitment and retention has increased by 124%....
Back to Newsroom